Browse Drug Recalls
514 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 514 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 514 FDA drug recalls in AZ.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Jul 14, 2023 | Neonatal TPN Starter Bag, Amino Acids (trophamine) 2%/Dextrose 10%, Total Vol... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | oxyTOCIN, 40 units added to 0.9% sodium chloride 1000 mL, IV Bag, Rx Only, Rx... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | CARDIOPLEGIA SOLUTION, HIGH K, Induction 4:1, Plasmalyte/Tromethamine, High P... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | vancomycin 1.5 g/250 mL added to 0.9% sodium chloride, 6 mg/mL, IV Bag, Rx on... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | dilTIAZem 125mg/125mL (1 mg/mL), added to 0.9% sodium chloride, IV Bag, Rx O... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | glycopyrrolate 1 mg/5 mL (0.2 mg/mL), For Anesthesia Use, Syringe, RX ONLY, C... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 10% with CALCI... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | heparin 2500 units/500mL added to 0.9% sodium chloride 5 units/mL, IV Bag, Rx... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | CARDIOPLEGIA SOLUTION, 60 mEq K, Induction 4:1, High Potassium, IV Bag, total... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | dilTIAZem 125mg/125mL (1 mg/mL), added to dextrose 5%, IV Bag, RX only, Cent... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | heparin 7500 units added to 0.9% sodium chloride 1000mL, CONCENTRATION = 7.5 ... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | NORepinephrine 4 mg/250 mL added to 0.9% sodium chloride 16 mcg/mL, IV Bag, R... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | heparin 4000 units/1000mL added to 0.9% sodium chloride, 4 units/mL, IV Bag, ... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | norepinephrine, 16 mg, added to dextrose 5% 250 mL, IV Bag, CONCENTRATION 64 ... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | CARDIOPLEGIA SOLUTION, 24 mEq K, Maintenance 8:1, Low Potassium, IV Bag, tota... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | potassium phosphate 15 mmole added to 0.9% sodium Chloride 250 mL, IV Bag, RX... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | oxyTOCIN 15 units added to 0.9% sodium chloride 250 mL, IV Bag, Rx only, Cent... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | oxyTOCIN 20 units added to 0.9% sodium chloride 1,000 mL, IV Bag, Rx only, Ce... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | Neonatal TPN Starter Bag, Amino Acids (trophamine) 3.5%/Dextrose 10% with **l... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | CARDIOPLEGIA SOLUTION, LEESBURG CARDIOPLEGIA, IV Bag, Total Volume = 1030.2 m... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | vancomycin 1 g/250 mL added to 0.9% sodium chloride, 4 mg/mL, IV Bag, Rx onl... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | CARDIOPLEGIA SOLUTION, IV Bag, Total Volume = 1818 mL, CRYSTALLOID INDUCTION,... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | Neonatal TPN Starter Bag, Amino Acids (trophamine) 4%/Dextrose 10% with CALCI... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | CARDIOPLEGIA SOLUTION, 36 mEq K, Induction 4:1, High Potassium/Low tromethami... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | Neonatal TPN Starter Bag, Amino Acids (trophamine) 6%/Dextrose 10% with low c... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | EPINEPHrine, 2 mg added to dextrose 5% 250mL, Concentration = 8 mcg/mL, IV Ba... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | CARDIOPLEGIA SOLUTION, 24 mEq K, Maintenance 8:1 non-enriched, Low Potassium,... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | Neonatal TPN Starter Bag, Amino Acids (Trophamine) 3%/Dextrose 10%, total vol... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | Neonatal TPN Starter Bag, Amino Acids (trophamine) 3.5%/Dextrose 10%, total v... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | heparin 5000 units/500mL added to 0.9% sodium chloride, 10 units/mL, IV Bag, ... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | CARDIOPLEGIA SOLUTION, HIGH K, Induction 4:1 Plasmalyte, High Potassium, IV B... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | PHENYLephrine, 40mg/250ml, added to 0.9% sodium chloride, IV Bag, Rx Only, Ce... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | CARDIOPLEGIA SOLUTION, 100 mEq K, Induction 8:1, High Potassium / Low dextros... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | CARDIOPLEGIA SOLUTION 122 mEq K, Modified St. Thomas Formula High Potassium, ... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | vancomycin 750 mg/250 mL added to 0.9% Sodium Chloride, (3 mg/mL), IV Bag, Rx... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | Neonatal TPN Starter Bag, Amino Acids (trophamine) 2%/Dextrose 10% with CALCI... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | CARDIOPLEGIA SOLUTION, 20 mEq K, Maintenance 4:1, Low Potassium, IV Bag, tot... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | phenylephrine 50 mg added to 0.9% sodium chloride 250mL, CONCENTRATION = 200m... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | oxyTOCIN 30 units added to dextrose 5%/lactated ringers 500 mL, IV Bag, Rx On... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | phenylephrine, 25mg added to 0.9% sodium chloride 250 mL, IV Bag, Rx Only, C... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | CARDIOPLEGIA SOLUTION, 48 mEq K, Induction 4:1 in Ringer's, High Potassium, I... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | CARDIOPLEGIA SOLUTION, 15 mEq K, Reperfusate 4:1, low potassium, IV Bag, tot... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 5% with **low ... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | oxyTOCIN 30 units added to Lactated Ringer's 500 mL, IV Bag, Rx only, Rx only... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | CARDIOPLEGIA SOLUTION, 108 mEq K, Induction 8:1, High Potassium, IV Bag, tota... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | vancomycin 1.5 g/250mL added to 5% dextrose, 6 mg/mL, IV Bag, Rx only, Cental... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Jul 14, 2023 | Neonatal TPN Starter Bag, Amino Acids (trophamine) 3%/Dextrose 5% with CALCIU... | Lack of assurance of sterility. Validation data for decontamination cycles is lacking. | Class II | Central Admixture Pharmacy Services, Inc. |
| Feb 14, 2023 | Purely Soothing MSM Nasal Spray, 15%, packaged in 30ml, 1.014 fl. oz bottles,... | CGMP Deviations | Class II | Pharmedica USA, LLC |
| Feb 14, 2023 | Purely Soothing 15% MSM Drops, packaged in a)15 ml, .5 fl oz bottle, UPC 7 31... | Non-Sterility | Class I | Pharmedica USA, LLC |
| Apr 21, 2022 | TORCO RACING FUELS HAND SANITIZER, Alcohol Antiseptic 80% Topical Solution, H... | CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specificatio... | Class II | Torco Race Fuels |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.